Skip to main content

Fiasp 100 units/mL (U-100) injection Images

Generic Name: insulin aspart

This medication has been identified as Fiasp 100 units/mL (U-100) injection. It is supplied by Novo Nordisk.

Fiasp is used in the treatment of Type 2 Diabetes; Diabetes, Type 1 and belongs to the drug class insulin. There is no proven risk in humans during pregnancy. Fiasp 100 units/mL (U-100) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Fiasp 100 units/mL (U-100) injection medicine

Fiasp

Generic Name
insulin aspart
Strength
100 units/mL (U-100) injection
Availability
Prescription only
Drug Class
Insulin
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novo Nordisk
National Drug Code (NDC)
multiple

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.